2,752 results on '"bone tumor"'
Search Results
2. Endoprosthesis Metal Toxicity Study
- Author
-
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), National Institute on Aging (NIA), and Matthew T. Houdek, Principal Investigator
- Published
- 2024
3. EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy (EPIBONE)
- Published
- 2024
4. Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery (ADER)
- Published
- 2024
5. Radiological Evaluation of 3D Printed Porous Collars in Hip and Knee Resection Prostheses: Pilot Study. (COLLARS)
- Author
-
San Filippo Neri General Hospital, Istituto Ortopedico Rizzoli, and Azienda Ospedaliera Città della Salute e della Scienza di Torino
- Published
- 2024
6. Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery (Onco-QoL)
- Published
- 2024
7. The Assessment of Fatigue and Quality of Life in Patients With Bone Tumor (Fatigue-ONCO)
- Published
- 2024
8. Prognostic Signature in Osteosarcoma Based on Amino Acid Metabolism-Associated Genes.
- Author
-
Feng, Liwen, Chen, Yuting, Mei, Xiangping, Wang, Lei, Zhao, Wenjing, and Yao, Jiannan
- Abstract
Background: Osteosarcoma (OS) is undeniably a formidable bone malignancy characterized by a scarcity of effective treatment options. Reprogramming of amino acid (AA) metabolism has been associated with OS development. The present study was designed to identify metabolism-associated genes (MAGs) that are differentially expressed in OS and to construct a MAG-based prognostic risk signature for this disease. Methods: Expression profiles and clinicopathological data were downloaded from Gene Expression Omnibus (GEO) and UCSC Xena databases. A set of AA MAGs was obtained from the MSigDB database. Differentially expressed genes (DEGs) in GEO dataset were identified using "limma." Prognostic MAGs from UCSC Xena database were determined through univariate Cox regression and used in the prognostic signature development. This signature was validated using another dataset from GEO database. Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, single sample gene set enrichment analysis, and GDSC2 analyses were performed to explore the biological functions of the MAGs. A MAG-based nomogram was established to predict 1-, 3-, and 5-year survival. Real-time quantitative polymerase chain reaction, Western blot, and immunohistochemical staining confirmed the expression of MAGs in primary OS and paired adjacent normal tissues. Results: A total of 790 DEGs and 62 prognostic MAGs were identified. A MAG-based signature was constructed based on four MAGs: PIPOX, PSMC2, SMOX, and PSAT1. The prognostic value of this signature was successfully validated, with areas under the receiver operating characteristic curves for 1-, 3-, and 5-year survival of 0.714, 0.719, and 0.715, respectively. This MAG-based signature was correlated with the infiltration of CD56dim natural killer cells and resistance to several antiangiogenic agents. The nomogram was accurate in predictions, with a C-index of 0.77. The expression of MAGs verified by experiment was consistent with the trends observed in GEO database. Conclusion: Four AA MAGs were prognostic of survival in OS patients. This MAG-based signature has the potential to offer valuable insights into the development of treatments for OS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Bone tumors: state-of-the-art imaging.
- Author
-
Debs, Patrick, Ahlawat, Shivani, and Fayad, Laura M.
- Subjects
- *
MAGNETIC resonance imaging , *TECHNOLOGICAL innovations , *COMPUTED tomography , *RADIONUCLIDE imaging , *DISEASE relapse - Abstract
Imaging plays a central role in the management of patients with bone tumors. A number of imaging modalities are available, with different techniques having unique applications that render their use advantageous for various clinical purposes. Coupled with detailed clinical assessment, radiological imaging can assist clinicians in reaching a proper diagnosis, determining appropriate management, evaluating response to treatment, and monitoring for tumor recurrence. Although radiography is still the initial imaging test of choice for a patient presenting with a suspected bone tumor, technological innovations in the last decades have advanced the role of other imaging modalities for assessing bone tumors, including advances in computed tomography, magnetic resonance imaging, scintigraphy, and hybrid imaging techniques that combine two existing modalities, providing clinicians with diverse tools for bone tumor imaging applications. Determining the most suitable modality to use for a particular application requires familiarity with the modality in question, its advancements, and its limitations. This review highlights the various imaging techniques currently available and emphasizes the latest developments in imaging, offering a framework that can help guide the imaging of patients with bone tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. The diagnostic and prognostic value of tartrate-resistant acid phosphatase isoform 5b for giant cell tumor of bone.
- Author
-
Toda, Yu, Ogura, Koichi, Iwata, Shintaro, Kobayashi, Eisuke, Osaki, Shuhei, Fukushima, Suguru, Mawatari, Masaaki, and Kawai, Akira
- Subjects
- *
ACID phosphatase , *BONE resorption , *BIOMARKERS , *BONE cells , *DATABASES - Abstract
Background: Serum level of tartrate-resistant acid phosphatase 5b (TRACP5b) is an excellent serum marker of bone resorption. In patients with giant cell tumor of bone (GCTB), TRACP5b levels are reportedly elevated. This study investigated whether TRACP5b could be a diagnostic serum marker and be useful for detecting postoperative disease progression for GCTB. Methods: Cohort 1: We abstracted data from 120 patients with TRACP5b measurements from our database: 49 patients with GCTB and 71 patients non-GCTB. We compared serum TRACP5b values between the GCTB and non-GCTB groups. Cohort 2 included 47 patients with GCTB who had more than 6 months of follow-up and multiple TRACP5b values. For patients with local recurrence, TRACP5b change rate was calculated by comparing the TRACP5b value just before progression (a) with the value at the time of progression (b): Change rate = [(b)−(a)]/(a). In the non-progression group, the change rate was calculated from the two consecutive TRACP5b values, (c) and (d): Change rate =[(c)-(d)]/(c). We compared TRACP5b change rates between the progression and non-progression groups. Results: Cohort 1: The GCTB group had a significantly higher mean TRACP5b value (1756 ± 2021 mU/dL) than the non-GCTB group (415 ± 219 mU/dL) (p < 0.0001). Cohort 2: The mean TRACP5b change rate of the progression group was significantly higher than the non-progression group (8.53 ± 8.52 and 0.24 ± 0.27, respectively; p < 0.0001). Conclusion: TRACP5b is a useful diagnostic marker in GCTB. The rate of change in serum TRACP5b values is a highly sensitive marker for predicting local recurrence in GCTB. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Malawer type I/V proximal humerus reconstruction after tumor resection: a systematic review.
- Author
-
Aiba, Hisaki, Atherley O'Meally, Ahmed, Aso, Ayano, Tsukamoto, Shinji, Kimura, Hiroaki, Murakami, Hideki, Saito, Shiro, Sakai, Takao, Bordini, Barbara, Cosentino, Monica, Zuccheri, Federica, Manfrini, Marco, Donati, Davide Maria, and Errani, Costantino
- Abstract
Several reconstruction methods exist for Malawer type I/V proximal humerus reconstruction after bone tumor resection; however, no consensus has been reached regarding the preferred methods. We conducted a literature search on various types of proximal humerus oncologic reconstruction methods. We collected data on postoperative functional outcomes assessed based on Musculoskeletal Tumor Society (MSTS) scores, 5-year reconstruction survival rates, and complications. We calculated each reconstruction's weighted mean based on the sample size and standard errors. Complications were categorized based on the Henderson classification. Based on these integrated data, our primary objective is to propose an optimal strategy for proximal humerus reconstruction after bone tumor resection. We examined various reconstruction techniques, including modular prosthesis (752 patients in 21 articles), osteoarticular allograft (142 patients in 6 articles), allograft prosthesis composites (APCs) (236 patients in 12 articles), reverse shoulder total arthroplasty (141 patients in 10 articles), composite reverse shoulder total arthroplasty (33 patients in 4 articles), claviculo-pro-humero (CPH) technique (51 patients in 6 articles), and cement spacer (207 patients in 4 articles). Weighted mean MSTS scores were: modular prosthesis (73.8%), osteoarticular allograft (74.4%), APCs (79.2%), reverse shoulder total arthroplasty (77.0%), composite reverse shoulder total arthroplasty (76.1%), CPH technique (75.1%), and cement spacer (69.1%). Weighted 5-year reconstruction survival rates were modular prosthesis (85.4%), osteoarticular allograft (67.6%), APCs (85.2%), reverse shoulder total arthroplasty (84.1%), and cement spacer (88.0%). Reconstruction survival data was unavailable for composite reverse shoulder total arthroplasty and CPH technique. Major complications included shoulder joint instability: modular prosthesis (26.2%), osteoarticular allograft (41.5%), APCs (33.9%), reverse shoulder total arthroplasty (17%), composite reverse shoulder total arthroplasty (6.1%), CPH technique (2.0%), and cement spacer (8.7%). Aseptic loosening of the prosthesis occurred: modular prosthesis (3.9%) and reverse shoulder total arthroplasty (5.7%). Allograft fracture was observed in 54.9% of patients with osteoarticular allograft. The complication profiles differed among reconstruction methods. Weighted mean MSTS scores exceeded 70% in all methods except cement spacer, and the 5-year reconstruction survival rate surpassed 80% for all methods except osteoarticular allograft. Proximal humerus reconstruction after bone tumor resection should consider potential complications and patients' individual factors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Osteosarcoma of Mandible — A Case Report.
- Author
-
Kaimal, Vinitha G. and Pai, Anuradha
- Abstract
After plasma cell neoplasia, osteosarcoma is the most common primary bone tumor which accounts for 20% of all sarcomas. A malignant tumor is characterized by the formation of bone or osteoid by tumor cells. Long bones are the most common site of involvement. In the jaw bones, approximately 5% of involvement with an incidence of 1 in 1.5 million persons per year. It develops in a broad range of ages but is more common in the third and fourth decades, slightly more often in the mandible than in the maxilla. In this case report, a 24-year-old male patient reported a mass in the left mandible for the past 1 week which appeared after the third molar extraction. In the orthopantomogram, a loss of lamina dura and a change in the trabecular pattern was noted. Histopathological findings were suggestive of osteoblastic osteogenic sarcoma. The patient underwent a hemi-mandibulectomy followed by chemotherapy. The main aim of this case report was to focus on the importance of early diagnosis of this tumor based on clinical and radiographic examinations, particularly taking into account the fast progression and aggressiveness of this neoplasm. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Research trends of bone tumor treatment with 3D printing technology from 2013 to 2022: a bibliometric analysis.
- Author
-
Chu, Jia-Hao, Zhang, Yang, Jiang, Yi, Wu, Hai-Fan, Wang, Wen-Yi, Wang, Min, Zhang, Jia-Hui, Yan, Kun, and Yao, Xin-Miao
- Subjects
RAPID prototyping ,THREE-dimensional printing ,BIBLIOMETRICS ,BONE products ,TUMOR treatment - Abstract
Objective: Bibliometrics was employed in this study to determine the research trends in the worldwide application of 3D printing technology to treat bone tumors over the previous 10 years. Methods: Published from 2013 to 2022, the papers related to bone tumors treated with 3D printing were located in Web of Science Core Collection (WoSCC), PubMed, and Scopus. The screened articles were included in this bibliometric study. From these papers in WoSCC, information on annual publications, journals, keywords, countries, authors, institutions, and cited references were extracted and visualized with CiteSpace (version 6.1.R6) software to investigate the state of bone tumor treatment using 3D printing as well as research hotspots. The Carrot2 online visualization tool and Vosviewer software (version 1.6.20) were employed to visualize the publications from PubMed and Scopus, respectively, in order to ascertain the most popular research topics from both databases. Results: A total of 606, 233, and 364 publications were obtained from WoSCC, PubMed, and Scopus, respectively, between the years 2013 and 2022. In WoSCC, the peak number of publications was found in 2021, with 145 publications published. Acta Biomaterialia (11 publications) and World Neurosurgery (10 publications) were the most prolific journals, and Biomaterials was the journal cited the most (244 times). Yong Zhou was the most productive author with 14 publications, while Kwok-Chuen Wong (69 citations) and William F Enneking, (69 citations) possessed the most citations. The country with the largest quantity of publications was China (207). Among all institutions, Shanghai Jiao Tong University produced the most publications (29). Rapid prototyping was the keyword with the strongest citation burst (4.73). 'Reconstruction', 'surgery', 'resection', and 'design' caught the significant attention of researchers. 3D-printed materials, pelvic reconstruction, mandibular reconstruction, computer-assisted surgical techniques, photothermal therapy, and in vitro experiments were recognized as hot subjects and trends in current research. The most frequently occurring topics in Scopus are not significantly different from those found in WoSCC. The most prevalent research areas in PubMed encompass implant, patient-specific, bioceramic, models, and pelvic. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Global research development of chondrosarcoma from 2003 to 2022: a bibliometric analysis.
- Author
-
Hansong Duan, Jiatong Li, Jianfei Ma, Ting Chen, He Zhang, and Guanning Shang
- Subjects
BIBLIOMETRICS ,CHINA-United States relations ,CHONDROSARCOMA ,PROTON therapy ,SCHOLARLY periodicals - Abstract
Background: Chondrosarcomas are common primary malignant bone tumors; however, comprehensive bibliometric analysis in this field has not yet been conducted. Therefore, this study aimed to explore the research hotspots and trends in the field of chondrosarcoma through bibliometric analysis to help researchers understand the current status and direction of research in the field. Methods: Articles and reviews related to chondrosarcoma published between 2003 and 2022 were retrieved from the Web of Science. Countries, institutions, authors, journals, references, and keywords in this field were visualized and analyzed using CtieSpace and VOSviewer software. Results: Between 2003 and 2022, 4,149 relevant articles were found. The number of articles published on chondrosarcoma has increased significantly annually, mainly from 569 institutions in China and the United States, and 81 in other countries. In total, 904 authors participated in the publication of studies related to chondrosarcomas. Over the past 20 years, articles on chondrosarcoma have been published in 958 academic journals, with Skeletal Radiology having the highest number of publications. Furthermore, keywords such as "gene expression," "radiotherapy," "experience," and "apoptosis" have been popular in recent years. Conclusion: Over the past 20 years, the global trend in chondrosarcoma research has primarily been clinical research, with basic research as a supplement. In the future, communication and exchange between countries and institutions should be strengthened. Further, the future main research hotspots in the field of chondrosarcoma include mutated genes and signaling pathways, precision surgical treatment, proton therapy, radiation therapy, chemotherapy, immunotherapy, and other aspects. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Outcome of Endoprosthetic Hip Reconstruction Following Resection of Malignant Bone Tumors.
- Author
-
Khakzad, Thilo, Putzier, Michael, Paksoy, Alp, Rau, Daniel, Thielscher, Leonard, Taheri, Nima, Wittenberg, Silvan, and Märdian, Sven
- Subjects
- *
TOTAL hip replacement , *COMPLICATIONS of prosthesis , *PROSTHESIS-related infections , *QUESTIONNAIRES , *BONE tumors , *TREATMENT effectiveness , *FUNCTIONAL status , *RETROSPECTIVE studies , *AGE distribution , *HEALTH surveys , *HIP joint , *SURGICAL complications , *ARTIFICIAL joints , *QUALITY of life , *MEDICAL records , *ACQUISITION of data , *HEALTH outcome assessment , *EVALUATION - Abstract
Simple Summary: This study explored the long-term outcomes of patients who underwent hip replacement surgery following the removal of malignant tumors in the hip area. The main focus was to understand how well patients recovered in terms of physical function and quality of life. The study included 30 patients treated between 2010 and 2018, all of whom received interdisciplinary therapy, consisting of both systemic and surgical treatments. The follow-up period averaged a little over three years. The results showed that younger patients tended to have better physical function and overall quality of life after surgery. The study also revealed that complications like implant failure were relatively low, and no amputations were necessary. These findings suggest that this type of surgery, combined with comprehensive interdisciplinary care, can be a safe and effective option for managing hip tumors. Further research is needed to continue improving patient outcomes and tailoring treatments to individual needs. Introduction: Over the past few decades, tumor arthroplasty has evolved into an established therapeutic approach for addressing bone defects following tumor resection in the extremities. As the diagnosis has a significant impact on patients' lives, it is important to give clear expectations for functional recovery. Therefore, we investigated both the functional outcomes and the quality of life (QoL) after tumor arthroplasty for malignant hip tumors. Methods: This retrospective study included patients who had undergone resections of malignant hip tumors with consecutive modular hip arthroplasty between 2010 and 2018. Demographics, tumor entity, and complications stemming from both tumors and treatments were evaluated through the analysis of medical records and perioperative records. The assessment of functional outcomes was conducted with the following patient-reported outcome measures (PROMs): the Harris Hip Score (HHS), Musculoskeletal Tumor Society Score (MSTS), and the Short Form Survey 36 (SF-36). Furthermore, we performed subgroup analysis in two groups: one divided into survivors and non-survivors, as well as younger individuals (<57 years) and older individuals (>57 years). Results: A total of 30 patients were included in the study. At the time of follow-up, 19 patients were deceased. The average duration of follow-up was 3.2 (±2.51) years. The average age at the time of surgery was 60.3 (±15.20) years. Notably, there were no cases of amputation reported (0%). Five cases of implant failure were identified (16.67%). Among these, one was attributed to infection (3.3%), while four resulted from aseptic loosening (13.3%). In terms of functional outcomes, MSTS indicated good results (18 ± 7; range: 7–28; 60%), and the HHS demonstrated moderate outcomes (75.3%). Younger survivors (<57 years) exhibited notably superior results in terms of both the MSTS and physical functioning in the SF-36 (p = 0.03). Conclusion: In summary, this study shows declining tumor arthroplasty-related complications and satisfying functional outcomes as well as QoL. Noteworthy aspects include the relatively low rates of amputation and local tumor recurrences, which significantly favor the selection of appropriate therapeutic options. Moreover, the findings underscore the substantial impact of patients' age on overall functionality and engagement in daily activities. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Benign bone tumors in North East Indian population - A hospital-based study.
- Author
-
Chetia, Naba Pallab, Ahmed, Firdous, Gogoi, Sagarika, and Joseph, Albin
- Subjects
- *
CORE needle biopsy , *BENIGN tumors , *MAGNETIC resonance imaging , *GIANT cell tumors , *BANKING industry , *SPONTANEOUS fractures , *COMPUTED tomography , *OSTEOCHONDROMA - Abstract
Background: Primary bone tumors are relatively uncommon and constitute only 0.2-0.5% of all tumors in all ages in most series reported worldwide. Benign bone tumors are more common than the malignant bone tumors. Not many studies on benign bone tumors in the North Eastern Indian population are published in the available literature. Aims and Objectives: The current study was done with the aim to find out the epidemiological data on benign bone tumors in patients of the North-East Indian population who were admitted to the orthopedic department of a teaching institute. Materials and Methods: A hospital-based retrospective study with prospective effect was conducted on benign bone tumors in patients admitted to the Department of Orthopedics at our teaching institute from 2016 to 2020. Patients of all ages and both sexes with suspicion of bone tumors based on history and clinical examination were subjected to roentgenographic evaluation, including computed tomography (CT) scan and/or magnetic resonance imaging. Pre-operative core needle biopsy under C-arm/CT guidance or incisional biopsy was done for histological diagnosis, followed by appropriate intervention. Soft-tissue tumors and malignant bone tumors were excluded. Patients were followed up for recurrence, complications, and functional recovery. Results: Forty patients of bone tumors were treated out of 2288 patients admitted to the department (incidence of 1.75%). 29 were benign bone tumors with an incidence of 1.27%. Of 10-20 years age group was most commonly affected. Male preponderance with M: F=6.25:1. Femur (n=16) was the most commonly affected bone. Presenting features were swelling (n=18), pain (n=11), and pathological fracture (n=5). osteochondroma (n=15) was most common followed by giant cell tumor of bone (n=6). Treatment ranged from intralesional steroid to wide marginal excision based on histopathological diagnosis, the extent of tumor, anatomical location, and presenting symptoms. All patients were rehabilitated to activities of daily living at the final follow-up. No recurrence or any long-term complications were reported. Conclusion: This study gives epidemiological data on benign bone tumors, which can be used for setting up or upgrading dedicated oncological or oncosurgery institutes. A multicentric study on a large population in the future is suggested to obtain a larger data bank. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Lipidomics by Nuclear Magnetic Resonance Spectroscopy and Liquid Chromatography–High-Resolution Mass Spectrometry in Osteosarcoma: A Pilot Study.
- Author
-
Pontes, João Guilherme de Moraes, Jadranin, Milka, Assalin, Márcia Regina, Quintero Escobar, Melissa, Stanisic, Danijela, Costa, Tássia Brena Barroso Carneiro, van Helvoort Lengert, André, Boldrini, Érica, Morini da Silva, Sandra Regina, Vidal, Daniel Onofre, Liu, Leticia Huan Bacellar, Maschietto, Mariana, and Tasic, Ljubica
- Subjects
UNSATURATED fatty acids ,OSTEOSARCOMA ,MASS spectrometry ,LIPIDOMICS ,MIDDLE-income countries ,CHOLINE ,NUCLEAR magnetic resonance spectroscopy - Abstract
Cancer is a complex disease that can also affect the younger population; however, it is responsible for a relatively high mortality rate of children and youth, especially in low- and middle-income countries (LMICs). Besides that, lipidomic studies in this age range are scarce. Therefore, we analyzed blood serum samples from young patients (12 to 35 years) with bone sarcoma (osteosarcoma) and compared their lipidomics to the ones from the control group of samples, named healthy control (HC group), using NMR and LC-MS techniques. Furthermore, differences in the lipidomic profiles between OS patients with and without metastasis indicate higher glycerophosphocholine (GPC) and glycerophospholipid (GPL) levels in osteosarcoma and increased cholesterol, choline, polyunsaturated fatty acids (PUFAs), and glycerols during the metastasis. These differences, detected in the peripheral blood, could be used as biomarkers for liquid biopsy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. An Injectable Hydrogel System with Mild Photothermal Effects Combined with Ion Release for Osteosarcoma‐Related Bone Defect Repair.
- Author
-
Yao, Jiaxin, He, Qiya, Zheng, Xiaoyan, Shen, Shihong, Hui, Junfeng, and Fan, Daidi
- Subjects
- *
PHOTOTHERMAL effect , *CANCER relapse , *BONE products , *HYDROGELS , *BONE cells , *IONS - Abstract
Osteosarcoma, a common invasive malignant bone disease, presents therapeutic challenges due to the persistent problem of incomplete resection during surgical treatment. This often results in postoperative tumor recurrence and metastasis, and large‐scale bone defects are difficult to self‐repair, seriously affecting patient health. In this study, a dual‐ion doped organic‐inorganic composited SOH1(CP)1 injectable hydrogel system is successfully designed and constructed. This system consists of sericin protein grafted with hydrazide bonds, oxidized chondroitin sulfate, Se and Mg co‐doped HAp nanorods, and polydopamine‐coated CaO2 nanospheres. The system displays strong anti‐tumor activity due to its mild photothermal effects combined with the chemotherapeutic efficacy of SeO32−. Because the degradation behavior of hydrogel matches the bone repair cycle, including the nutritional support of hydrogel skeleton degradation products to promote bone cell proliferation, and the positive regulation of Ca2+, Mg2+, and PO43− released via the degradation of inorganic nanoparticles to promote bone differentiation, the system shows excellent bone defect repair efficacy. Importantly, this system achieves 100% tumor inhibition after 18 days, while ensuring complete bone repair after 12 weeks. Hence, the SOH1(CP)1 injectable hydrogel system, which displays both high anti‐osteosarcoma efficacy and strong bone repair properties, can serve as a new tool for osteosarcoma‐related bone defect repair. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Design and in vitro evaluation of 223Ra/99mTc-loaded spherical nano-hydroxyapatite in bone tumor therapy.
- Author
-
Wang, Yumei, Zhou, Yue, Zhai, Dongliang, Deng, Hao, and Chen, Xiaoliang
- Abstract
Aim: Nano-hydroxyapatite (nHA) is a good nanocarrier to load
223 Ra, but the low specific activity (sp.act.) of223 Ra@nHA limits its application in medicine. Methods: We proposed a method for preparing nHA using PEG as a template, which significantly increases the sp.act of223 Ra@nHA and a new method to loaded99m Tc for in vivo tracking. Results: The nHA synthesized using PEG as a template was associated with higher sp.act for223 Ra in comparison to nHA with identical particle size and without PEG. The nHA load99m Tc-MDP was associated with higher labeling rate and stability in comparison to99m Tc. Conclusion: All these findings suggest that using PEG as a template and99m Tc-MDP could be the most effective of synthetic223 Ra/99m Tc@nHA. Article highlights The excellent therapeutic effect of223 Ra in bone metastases prompted the exploration of nanomaterial labelled nuclide for enhancement of the efficacy of223 Ra in primary bone tumors treatment. A nanosystem for theranostic based on223 Ra and99m Tc-MDP labelled was developed, providing a potential new technology for in vivo tracer of223 Ra in tumor therapy. PEG@nHA nanoparticles have a particle size of 80–100 nm. The sp.act value of223 Ra is 74 kBq/mg, which is significantly higher than that of nHA(without) PEG with the same particle size (22.2kBq /mg). The 120-hour stability at different pH values indicated that the release rate of223 Ra from223 Ra@nHA was significantly increased under the acidic condition at pH 4.0, which might ensure the effective release of the drug at the tumor site.223 Ra@nHA has excellent stability, and the stability is ≥95% after 7 days in FBS and PBS. The labeling efficiency and stability of99m Tc@nHA were lower than that of99m Tc-MDP based nHA labeling method. Simultaneous labeling of223 Ra and99m Tc does not affect the loading capacity of nuclides and the stability after loading of nanomaterials.223 Ra/99m TcM@nHA nanoparticles have generated stronger cell death effect. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
20. Research trends of bone tumor treatment with 3D printing technology from 2013 to 2022: a bibliometric analysis
- Author
-
Jia-Hao Chu, Yang Zhang, Yi Jiang, Hai-Fan Wu, Wen-Yi Wang, Min Wang, Jia-Hui Zhang, Kun Yan, and Xin-Miao Yao
- Subjects
3D printing ,Bone tumor ,Bibliometric analysis ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Objective Bibliometrics was employed in this study to determine the research trends in the worldwide application of 3D printing technology to treat bone tumors over the previous 10 years. Methods Published from 2013 to 2022, the papers related to bone tumors treated with 3D printing were located in Web of Science Core Collection (WoSCC), PubMed, and Scopus. The screened articles were included in this bibliometric study. From these papers in WoSCC, information on annual publications, journals, keywords, countries, authors, institutions, and cited references were extracted and visualized with CiteSpace (version 6.1.R6) software to investigate the state of bone tumor treatment using 3D printing as well as research hotspots. The Carrot2 online visualization tool and Vosviewer software (version 1.6.20) were employed to visualize the publications from PubMed and Scopus, respectively, in order to ascertain the most popular research topics from both databases. Results A total of 606, 233, and 364 publications were obtained from WoSCC, PubMed, and Scopus, respectively, between the years 2013 and 2022. In WoSCC, the peak number of publications was found in 2021, with 145 publications published. Acta Biomaterialia (11 publications) and World Neurosurgery (10 publications) were the most prolific journals, and Biomaterials was the journal cited the most (244 times). Yong Zhou was the most productive author with 14 publications, while Kwok-Chuen Wong (69 citations) and William F Enneking, (69 citations) possessed the most citations. The country with the largest quantity of publications was China (207). Among all institutions, Shanghai Jiao Tong University produced the most publications (29). Rapid prototyping was the keyword with the strongest citation burst (4.73). ‘Reconstruction’, ‘surgery’, ‘resection’, and ‘design’ caught the significant attention of researchers. 3D-printed materials, pelvic reconstruction, mandibular reconstruction, computer-assisted surgical techniques, photothermal therapy, and in vitro experiments were recognized as hot subjects and trends in current research. The most frequently occurring topics in Scopus are not significantly different from those found in WoSCC. The most prevalent research areas in PubMed encompass implant, patient-specific, bioceramic, models, and pelvic.
- Published
- 2024
- Full Text
- View/download PDF
21. Benign bone tumors in North East Indian population – A hospital-based study
- Author
-
Naba Pallab Chetia, Firdous Ahmed, Sagarika Gogoi, and Albin Joseph
- Subjects
bone tumor ,benign ,diagnosis ,Medicine - Abstract
Background: Primary bone tumors are relatively uncommon and constitute only 0.2–0.5% of all tumors in all ages in most series reported worldwide. Benign bone tumors are more common than the malignant bone tumors. Not many studies on benign bone tumors in the North Eastern Indian population are published in the available literature. Aims and Objectives: The current study was done with the aim to find out the epidemiological data on benign bone tumors in patients of the North-East Indian population who were admitted to the orthopedic department of a teaching institute. Materials and Methods: A hospital-based retrospective study with prospective effect was conducted on benign bone tumors in patients admitted to the Department of Orthopedics at our teaching institute from 2016 to 2020. Patients of all ages and both sexes with suspicion of bone tumors based on history and clinical examination were subjected to roentgenographic evaluation, including computed tomography (CT) scan and/or magnetic resonance imaging. Pre-operative core needle biopsy under C-arm/CT guidance or incisional biopsy was done for histological diagnosis, followed by appropriate intervention. Soft-tissue tumors and malignant bone tumors were excluded. Patients were followed up for recurrence, complications, and functional recovery. Results: Forty patients of bone tumors were treated out of 2288 patients admitted to the department (incidence of 1.75%). 29 were benign bone tumors with an incidence of 1.27%. Of 10–20 years age group was most commonly affected. Male preponderance with M: F=6.25:1. Femur (n=16) was the most commonly affected bone. Presenting features were swelling (n=18), pain (n=11), and pathological fracture (n=5). osteochondroma (n=15) was most common followed by giant cell tumor of bone (n=6). Treatment ranged from intralesional steroid to wide marginal excision based on histopathological diagnosis, the extent of tumor, anatomical location, and presenting symptoms. All patients were rehabilitated to activities of daily living at the final follow-up. No recurrence or any long-term complications were reported. Conclusion: This study gives epidemiological data on benign bone tumors, which can be used for setting up or upgrading dedicated oncological or oncosurgery institutes. A multicentric study on a large population in the future is suggested to obtain a larger data bank.
- Published
- 2024
- Full Text
- View/download PDF
22. Osteoid osteoma presentation at the center of the scapula neck in an overhead athlete: a case report
- Author
-
Daisuke Yamashita, MD, Atushi Tasaki, MD, PhD, Takayuki Oishi, MD, PhD, Taiki Nozaki, MD, PhD, and Nobuto Kitamura, MD, PhD
- Subjects
Osteoid osteoma ,Suprascapular nerve ,Scapula ,Benign tumor ,Shoulder joint ,Bone tumor ,Surgery ,RD1-811 - Published
- 2024
- Full Text
- View/download PDF
23. The Role of Denosumab in the Treatment of Primary Tumors of Bone.
- Author
-
Wessel, Lauren, Strike, Sophia, Singh, Arun, Bernthal, Nicholas, and Athanasian, Edward
- Subjects
RANK ,bone tumor ,denosumab ,giant cell tumor ,hand tumor ,Humans ,Denosumab ,Bone Density Conservation Agents ,Giant Cell Tumor of Bone ,Bone and Bones ,Bone Neoplasms - Abstract
Many hand surgeons treat benign bone tumors without referral to orthopedic oncologists. However, there have been considerable advances in medical therapy for some of these tumors, with which hand surgeons may not be as familiar. This review focuses on the mechanism and uses of denosumab in the treatment of benign tumors of bone. Although the hand surgeon may not be directly prescribing this therapy, they are often the only physician treating the patient for these conditions. As such, awareness regarding the use of this therapy in reducing pain, decreasing tumor volume, and treatment of potential lung metastases is critical to those taking on these cases without the support of an orthopedic oncologist. This article aims to familiarize hand surgeons with denosumab to help promote knowledge of this therapeutic option and the potential role of this medication in the treatment of primary bone tumors in the hand.
- Published
- 2023
24. Bone Tumor Diagnosis
- Author
-
Johnson, Lent, Mulligan, Michael, Johnson, Lent, and Mulligan, Michael
- Published
- 2024
- Full Text
- View/download PDF
25. Ewing’s Sarcoma
- Author
-
Albergo, Jose Ignacio, Aponte-Tinao, Luis Alberto, Slullitel, Pablo, editor, Rossi, Luciano, editor, and Camino-Willhuber, Gastón, editor
- Published
- 2024
- Full Text
- View/download PDF
26. Osteosarcoma
- Author
-
Farfalli, German Luis, Albergo, Jose Ignacio, Slullitel, Pablo, editor, Rossi, Luciano, editor, and Camino-Willhuber, Gastón, editor
- Published
- 2024
- Full Text
- View/download PDF
27. Magnetic Resonance Imaging of Primary Bone Tumors of the Spine
- Author
-
Riahi, Hend, Mars, Mokhtar, Chaabouni, Mohamed, Chelli Bouaziz, Mouna, Ladeb, Mohamed Fethi, Ladeb, Mohamed Fethi, editor, and Vanhoenacker, Filip, editor
- Published
- 2024
- Full Text
- View/download PDF
28. A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors
- Author
-
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Published
- 2023
29. Do Pathologic Fractures in Long Bone Following Bony Malignancy Increase the Risk of Venous Thromboembolism? A Comparative Study
- Author
-
Sanjay Kumar Rai, Tej Pratap Gupta, Bhavya Sirohi, Surbhi Rajauria, and Nitish Khandelwal
- Subjects
bone tumor ,bony metastasis ,deep vein thrombosis ,deep vein thrombosis prophylaxis ,pathologic long bone fracture ,Orthopedic surgery ,RD701-811 - Abstract
Background: Venous thrombosis is a dreaded complication of long bone fractures. The occurrence of deep vein thrombosis (DVT) may be high in specific cases such as bone tumors with pathological fractures. In this regard, more work is required to establish its correlation. Scanty data are available that shows whether pathological fractures increase the risk of DVT by comparing fracture fixation and replacement surgeries as a treatment. The anticoagulation protocols in published literature might not be suitable for this specific group. Materials and Methods: In a retrospective study on patients who underwent surgeries for pathological fracture fixation between September 2010 and October 2020. Their data were collected and analyzed. DVT is diagnosed by clinical sign, D-dimer test, and using color Doppler. The study population (n = 68) was compared and paired with a control group (n = 140) with similar baseline characteristics. Results: There were 12 patients (17.64%) in the study group and 8 (5.71%) patients in the control group that developed DVT after performing risk ratio and Student’s t-test and calculating odds ratio (P < 0.031). There was a statistically significant correlation found between the development of DVT with the type of implant used, the presence of neoplastic lesions, and the presence of metastases. Conclusion: Patients with a pathological long bone fracture who underwent surgical management are at greater risk for DVT or death due to pulmonary embolism under the current recommended thromboprophylaxis protocol. This risk of developing DVT is increased much fold in the presence of metastasis, chemotherapy, radiotherapy, fracture fixation, and arthroplasty.
- Published
- 2024
- Full Text
- View/download PDF
30. An Unusual Case of Primary Aneurysmal Bone Cyst of the Patella with a Review of Literature
- Author
-
Girish Mugdum, Rajiv Kaul, and Anil Kumar Mishra
- Subjects
aneurysmal bone cyst ,bone tumor ,patella ,patellectomy ,skeletal neoplasms ,Orthopedic surgery ,RD701-811 - Abstract
Tumors of the patella are uncommon. A 28-year-old male, who presented with intermittent knee pain of 9 months duration, with swelling and tenderness over the patella underwent a clinico-radiological evaluation which revealed fluid-fluid levels, suggestive of an aneurysmal bone cyst (ABC). Conventional treatment of ABCs usually consists of curettage and autologous bone grafting. However, in this case, a total patellectomy resulted in full functional restoration and resumption of activities, thereby ascertaining this method as a successful treatment option for primary ABC of the patella.
- Published
- 2024
- Full Text
- View/download PDF
31. Fluoroscopically calibrated 3D-printed patient-specific instruments improve the accuracy of osteotomy during bone tumor resection adjacent to joints
- Author
-
Chen Wang, Siyi Huang, Yue Yu, Haijie Liang, Ruifeng Wang, Xiaodong Tang, and Tao Ji
- Subjects
3D printed patient-specific instrument ,Joint-preserving surgery ,Bone tumor ,Accuracy ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Abstract
Abstract Background Inadequate surface matching, variation in the guide design, and soft tissue on the skeletal surface may make it difficult to accurately place the 3D-printed patient-specific instrument (PSI) exactly to the designated site, leading to decreased accuracy, or even errors. Consequently, we developed a novel 3D-printed PSI with fluoroscopy-guided positioning markers to enhance the accuracy of osteotomies in joint-preserving surgery. The current study was to compare whether the fluoroscopically calibrated PSI (FCPSI) can achieve better accuracy compared with freehand resection and conventional PSI (CPSI) resection. Methods Simulated joint-preserving surgery was conducted using nine synthetic left knee bone models. Osteotomies adjacent to the knee joint were designed to evaluate the accuracy at the epiphysis side. The experiment was divided into three groups: free-hand, conventional PSI (CPSI), and fluoroscopically Calibrated PSI (FCPSI). Post-resection CT scans were quantitatively analyzed. Analysis of variance (ANOVA) was used. Result FCPSI improved the resection accuracy significantly. The mean location accuracy is 2.66 mm for FCPSI compared to 6.36 mm (P
- Published
- 2024
- Full Text
- View/download PDF
32. Preliminary exploration of amide proton transfer weighted imaging in differentiation between benign and malignant bone tumors.
- Author
-
Ying Li, Liangjie Lin, Yong Zhang, Cuiping Ren, Wenhua Zhang, and Jingliang Cheng
- Subjects
RECEIVER operating characteristic curves ,MAGNETIZATION transfer ,BENIGN tumors ,PROTONS ,SURGICAL pathology ,TUMORS ,PELVIC bones - Abstract
Purpose: To explore the value of 3D amide proton transfer weighted imaging (APTWI) in the differential diagnosis between benign and malignant bone tumors, and to compare the diagnostic performance of APTWI with traditional diffusionweighted imaging (DWI). Materials and methods: Patients with bone tumors located in the pelvis or lower limbs confirmed by puncture or surgical pathology were collected from January 2021 to July 2023 in the First Affiliated Hospital of Zhengzhou University. All patients underwent APTWI and DWI examinations. The magnetization transfer ratio with asymmetric analysis at the frequency offset of 3.5 ppm [MTRasym(3.5 ppm)] derived by APTWI and the apparent diffusion coefficient (ADC) derived by DWI for the tumors were measured. The Kolmogorou-Smirnou and Levene normality test was used to confirm the normal distribution of imaging parameters; and the independent sample t test was used to compare the differences in MTRasym(3.5 ppm) and ADC between benign and malignant bone tumors. In addition, the receiver operating characteristic (ROC) curve was used to evaluate the diagnostic performance of different imaging parameters in differentiation between benign and malignant bone tumors. P<0.05 means statistically significant. Results: Among 85 bone tumor patients, 33 were benign and 52 were malignant. The MTRasym(3.5 ppm) values of malignant bone tumors were significantly higher than those of benign tumors, while the ADC valueswere significantly lower in benign tumors. ROC analysis shows thatMTRasym(3.5 ppm) and ADC values perform well in the differential diagnosis of benign and malignant bone tumors, with the area under the ROC curve (AUC) of 0.798 and 0.780, respectively. Combination of MTRasym(3.5 ppm) and ADC values can further improve the diagnostic performance with the AUC of 0.849 (sensitivity = 84.9% and specificity = 73.1%). Conclusion: MTRasym(3.5 ppm) ofmalignant bone tumors was significantly higher than that of benign bone tumors, reflecting the abnormal increase of protein synthesis in malignant tumors. APTWI combined with DWI can achieve a high diagnostic efficacy in differentiation between benign and malignant bone tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Anevrizmal Kemik Kistlerinde Nüks Oluşumunu Etkileyen Faktörler ve Cerrahi Tedavi Sonuçları.
- Author
-
ENGİN, Ertürk, KAYA, İbrahim, ÇELTİK, Mustafa, BİRCAN, Resul, MISIRLIOĞLU, Mesut, and GÜNGÖR, Bedii Şafak
- Subjects
- *
RISK assessment , *OPEN reduction internal fixation , *CANCER relapse , *ANEURYSMAL bone cyst , *SEX distribution , *BONE tumors , *TREATMENT effectiveness , *RETROSPECTIVE studies , *AGE distribution , *DESCRIPTIVE statistics , *OPERATIVE surgery , *SURGICAL complications , *MEDICAL records , *ACQUISITION of data , *DISEASE risk factors - Abstract
Background: aim of this study was to investigate the long-term clinical, functional and oncologic outcomes of patients with aneurysmal bone cyst (ABC). It was also aimed to reveal the effect of treatment options on recurrence and complications. Materials and Methods: Patients who underwent surgical treatment and follow-up with the diagnosis of ACS between 2000 and January 2023 were included in the study. Data were collected retrospectively using the hospital database and patient follow- up files. Only patients with a histologically confirmed diagnosis of ABC and a minimum follow-up period of 12 months were included in the study. Data such as age, gender, side, bone location of the tumor, extremity localization, preferred surgical method (curettage+allograft, curettage+allograft, curettage+autograft, curettage+cement and resection), whether internal fixation was applied, follow-up period, presence of recurrence and date of recurrence were recorded. The last follow-up was performed with the MSTS (Musculoskeletal Tumor Society) scoring system in outpatient clinic controls. On the basis of these data, the clinical, radiological, functional and oncological outcomes of the patients, complication rates, presence of recurrence and factors affecting the occurrence of recurrence were retrospectively analyzed. Results: A total of 103 patients, 51 women and 52 men, were included in the study. The mean follow-up period was 30.94±4.43 months. Recurrence was seen in 24.3% (n=25) of the patients. The age of patients with recurrence was significantly higher than those without recurrence (p<0.001). There was a statistically significant correlation between recurrence and internal fixation (p=0.020). The MSTS scores of patients who underwent internal fixation during surgery were significantly higher than those of patients who did not undergo internal fixation (p<0.001). Conclusions: In conclusion, in line with the data obtained in our study, the choice of treatment for aneurysmal bone cysts depends on localization, size, pathological fracture risk, symptoms and surrounding tissues. We believe that more caution should be exercised in the surgical treatment of ACCs with fracture risk, lower extremity localizations, and patients with incomplete skeletal development. Prevention of recurrence and internal fixation in patients with fracture risk increase patient satisfaction and positively affect functional outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. En Bloc Surgery in the Thoracic Spine: Indications, Results, and Complications in a Series of Eighty-Five Patients Affected by Primary and Secondary Malignant Bone Tumors.
- Author
-
Luzzati, Alessandro, Pizzigallo, Carmela, Sperduti, Isabella, Scotto di Uccio, Alessandra, Mazzoli, Simone, Cannavò, Luca, Scotto, Gennaro, and Zoccali, Carmine
- Subjects
- *
THORACIC vertebrae , *CHORDOMA , *SECONDARY primary cancer , *THORACIC surgery , *SPINAL surgery , *SURGICAL margin , *TUMORS - Abstract
En bloc resection remains the cornerstone treatment for malignant bone tumors affecting the spine. The thoracic spine poses unique challenges because of the proximity of crucial structures. This study assesses outcomes of patients who underwent en bloc spondylectomy for malignant bone tumors at the thoracic level. We retrospectively reviewed 85 cases of primary and secondary bone tumors in the thoracic spine, undergoing en bloc spondylectomy from 1996 to 2016. Evaluation encompassed clinical presentation, tumor characteristics, surgical outcomes, complications, survival, and recurrence. Of 85 patients, 40 presented directly, whereas 45 had undergone previous intralesional surgery. Chondrosarcoma and chordoma comprised the most prevalent primary histologic types; thyroid and kidney carcinomas were the most frequent secondary tumors. Pain was reported in 75 patients at diagnosis. Margins were adequate in 54 cases and intralesional in 31. Immediate postoperative deaths amounted to 4. Major complications included substantial blood loss, neurologic deterioration, and paraplegia. The 5-year local recurrence-free survival was 58.7%, significantly influenced by the surgical margin: patients with wide margins experienced a 5-year local recurrence-free survival of 85.7%, whereas those with marginal and intralesional margins had rates of 56.7% and 45.6%, respectively; overall recurrence was 22.3%, with no notable disparities between previously treated and untreated patients. The 5-year overall survival was 63.2% and 56.2% for primary and secondary tumors, respectively. The overall survival was not significantly influenced by surgical margins. Managing malignant thoracic bone tumors poses significant challenges. This study underscores the criticality of achieving adequate margins, particularly after previous intralesional approaches. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Clinical Application of Unidirectional Porous Hydroxyapatite to Bone Tumor Surgery and Other Orthopedic Surgery.
- Author
-
Kunisada, Toshiyuki, Nakata, Eiji, Fujiwara, Tomohiro, Hata, Toshiaki, Sato, Kohei, Katayama, Haruyoshi, Kondo, Ayana, and Ozaki, Toshifumi
- Subjects
- *
ORTHOPEDIC surgery , *BONE surgery , *CLINICAL medicine , *FIBULA , *CHILD patients ,TUMOR surgery - Abstract
Unidirectional porous hydroxyapatite (UDPHAp) was developed as a remarkable scaffold characterized by a distinct structure with unidirectional pores oriented in the horizontal direction and connected through interposes. We evaluated the radiographic changes, clinical outcomes, and complications following UDPHAp implantation for the treatment of bone tumors. Excellent bone formation within and around the implant was observed in all patients treated with intralesional resection and UDPHAp implantation for benign bone tumors. The absorption of UDPHAp and remodeling of the bone marrow space was observed in 45% of the patients at a mean of 17 months postoperatively and was significantly more common in younger patients. Preoperative cortical thinning was completely regenerated in 84% of patients at a mean of 10 months postoperatively. No complications related to the implanted UDPHAp were observed. In a pediatric patient with bone sarcoma, when the defect after fibular resection was filled with UDPHAp implants, radiography showed complete resorption of the implant and clear formation of cortex and marrow in the resected part of the fibula. The patient could walk well without crutches and participate in sports activities. UDPHAp is a useful bone graft substitute for the treatment of benign bone tumors, and the use of this material has a low complication rate. We also review and discuss the potential of UDPHAp as a bone graft substitute in the clinical setting of orthopedic surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Periosteal chondroblastoma of the femoral neck: two cases and a review of the literature.
- Author
-
Guillois, Clovis, Yang, Sisi, Biau, David, Feydy, Antoine, and Larousserie, Frédérique
- Subjects
- *
FEMUR neck , *LITERATURE reviews , *BENIGN tumors - Abstract
Chondroblastoma is a rare benign cartilaginous tumor mostly confined to the epiphyses and apophyses. Cases outside the epiphyseal region are exceedingly rare. Extramedullary chondroblastomas are exceptional; to our knowledge, only two cases qualified as "periosteal chondroblastoma" have been described in the literature. We report two cases of metaphyseal periosteal chondroblastoma both located on the inferior surface of the femoral neck. Both cases were paucicellular with an unusual dense sclerotic reaction. The diagnosis of chondroblastoma was supported by the expression of histone 3.3, K36M mutant in tumor cells. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Unusual presentation of tumor‐induced osteomalacia mismanaged due to misdiagnosis: A literature review based on a case report.
- Author
-
Fatollahzadeh, Mahdieh, Meybodi, Hamid Reza Aghaei, Pajavand, Hamid, Payab, Moloud, Ebrahimpur, Mahbube, and Ebrahimi, Pouya
- Subjects
- *
LITERATURE reviews , *BONE fractures , *OSTEOMALACIA , *FIBROBLAST growth factors , *PHYSICIANS , *DELAYED diagnosis - Abstract
Key Clinical Message: Tumor‐induced osteomalacia is a rare but potentially serious disease with nonspecific misguiding manifestations that can result in a wrong diagnosis and being treated for rheumatologic or other similar diseases. In patients with unexpected fractures, resistant musculoskeletal pains, and hypophosphatemia, this diagnosis should be considered by the physicians and approached through a complete history taking, physical exam laboratory, and radiologic evaluation to give the opportunity of on‐time treatment to the patient. Tumor‐induced osteomalacia (TIO) is an uncommon mesenchymal tumor that results in disproportionate phosphorus excretion, primarily leading to bone‐related symptoms. Laboratory, imaging, and histopathological evaluation can confirm this pathologic condition. In this case, we present the history and subsequent clinical parts of a 50‐year‐old woman who presented with an unusual presentation of generalized musculoskeletal pains and a right ankle mass. Her disease was diagnosed with multidisciplinary evaluation and was approached by a surgical treatment. The patient was treated with total resection of the tumor, which led to complete resolution of musculoskeletal and metabolic abnormalities, which were resolved following total tumor resection. TIO is a paraneoplastic disease that results in abnormal secretion of phosphatonins, particularly fibroblast growth factor 23 (FGF23). This can cause hypophosphatemia, hyperparathyroidism, lower bone density, and increased risk of pathologic fractures. These tumors are mostly cured by surgical ± radiotherapy. The present study aims to provide insight into the fact that a TIO diagnosis is not always straightforward. However, in suspicious cases such as unexplained hypophosphatemia, it should be considered to prevent delayed diagnosis of the progressive pathology. The earlier treatment can prevent several complications and reduce the risk of mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Optimal design of bone tumor ablation device based on radio frequency heating using Taguchi method.
- Author
-
Lee, Gyoung Jun, Jin, Sangrok, and Joo, Min Wook
- Abstract
This study investigated the optimal design of a radio-frequency (RF) bone tumor ablation device to achieve uniform heating. In a previous study, we confirmed the feasibility of this device, which could heat all regions of the bone to 70 °C or higher and maintain this temperature for more than 30 min. However, the temperature in each part was non-uniform. To address this issue, the shape of the electrode must be modified to create a uniform electric field. The design of the electrode was optimized to reduce temperature deviations. It is difficult to analytically model the relationship between the shape of the electrode and the electric field. The electrode's design factors were fine-tuned using the Taguchi method, a robust design of experiment approach. The primary objective in this optimization was to maximize the signal-to-noise ratio for temperature in each component, aiming for higher values. After four trials, the signal-to-noise ratio increased in comparison with the initial modified shape from 68.3 to 98.6. The experiment was conducted using an experimental device fabricated using the optimal design factors. In comparison to the previous experiment, the temperature standard deviation per part over time decreased from 10.56 °C 4.28 °C. The experimental results demonstrated the validity of the proposed optimal design approach. In the future, the proposed method can be used to optimize the design factors when a product is advanced to develop a device that can be applied to the human body. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. A Systematic Review and Meta-Analysis of the Outcomes of Reconstruction with Vascularised vs Non-Vascularised Bone Graft after Surgical Resection of Primary Malignant and Non-Malignant Bone Tumors.
- Author
-
PATEL, R., MCCONAGHIE, G., KHAN, M. M., GIBSON, W., SINGH, R., and BANERJEE, R.
- Subjects
BONE grafting ,SURGICAL excision ,TUMOR surgery ,SURGICAL complications ,ONLINE databases ,TUMORS - Abstract
PURPOSE OF THE STUDY Vascularised bone grafting (VBG) and non-vascularised bone grafting (NVBG) are crucial biological reconstructive procedures extensively employed in the management of bone tumours. The principal aim of this study is to conduct a comparative analysis of the post-resection outcomes associated with the utilisation of vascularised and non-vascularised bone grafts. MATERIAL AND METHODS A comprehensive and systematic literature review spanning the years 2013 to 2023 was meticulously executed, utilising prominent online databases including PubMed/Medline, Google Scholar, and Cochrane Library. Inclusion criteria were restricted to comparative articles that specifically addressed outcomes pertaining to defect restoration following bone tumour resection via vascularised and non-vascularised bone grafting techniques. The quality of research methodologies was assessed using the Oxford Quality Scoring System for randomised trials and the Newcastle Ottawa Scale for non-randomised comparative studies. Data analysis was conducted using SPSS version 24. Key outcome measures encompassed the Musculoskeletal Tumour Society Score (MSTS), bone union duration, and the incidence of post-operative complications. RESULTS This analysis incorporated four clinical publications, enrolling a total of 178 participants (comprising 92 males and 86 females), with 90 patients subjected to VBG and 88 to NVBG procedures. The primary endpoints of interest encompassed MSTS scores and bone union durations. Although no statistically significant distinction was observed in the complication rates between the two cohorts, it is noteworthy that VBG exhibited a markedly superior bone union rate (P<0.001). CONCLUSIONS Our systematic evaluation revealed that VBG facilitates expedited bone union, thereby contributing to accelerated patient recovery. Notably, complication rates and functional outcomes were comparable between the VBG and NVBG groups. Moreover, the correlation between bone union duration and functional scores following VBG and NVBG merits further investigation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Fluoroscopically calibrated 3D-printed patient-specific instruments improve the accuracy of osteotomy during bone tumor resection adjacent to joints.
- Author
-
Wang, Chen, Huang, Siyi, Yu, Yue, Liang, Haijie, Wang, Ruifeng, Tang, Xiaodong, and Ji, Tao
- Subjects
TUMOR surgery ,KNEE joint ,OSTEOTOMY ,COMPUTED tomography ,ANALYSIS of variance - Abstract
Background: Inadequate surface matching, variation in the guide design, and soft tissue on the skeletal surface may make it difficult to accurately place the 3D-printed patient-specific instrument (PSI) exactly to the designated site, leading to decreased accuracy, or even errors. Consequently, we developed a novel 3D-printed PSI with fluoroscopy-guided positioning markers to enhance the accuracy of osteotomies in joint-preserving surgery. The current study was to compare whether the fluoroscopically calibrated PSI (FCPSI) can achieve better accuracy compared with freehand resection and conventional PSI (CPSI) resection. Methods: Simulated joint-preserving surgery was conducted using nine synthetic left knee bone models. Osteotomies adjacent to the knee joint were designed to evaluate the accuracy at the epiphysis side. The experiment was divided into three groups: free-hand, conventional PSI (CPSI), and fluoroscopically Calibrated PSI (FCPSI). Post-resection CT scans were quantitatively analyzed. Analysis of variance (ANOVA) was used. Result: FCPSI improved the resection accuracy significantly. The mean location accuracy is 2.66 mm for FCPSI compared to 6.36 mm (P < 0.001) for freehand resection and 4.58 mm (P = 0.012) for CPSI. The mean average distance is 1.27 mm compared to 2.99 mm (p < 0.001) and 2.11 mm (p = 0.049). The mean absolute angle is 2.16° compared to 8.50° (p < 0.001) and 5.54° (p = 0.021). The mean depth angle is 1.41° compared to 8.10° (p < 0.001) and 5.32° (p = 0.012). However, there were no significant differences in the front angle compared to the freehand resection group (P = 0.055) and CPSI (P = 0.599) group. The location accuracy observed with FCPSI was maintained at 4 mm, while CPSI and freehand resection exhibited a maximum deviation of 8 mm. Conclusion: The fluoroscopically calibrated 3D-printed patient-specific instruments improve the accuracy of osteotomy during bone tumor resection adjacent to joint joints compared to conventional PSI and freehand resection. In conclusion, this novel 3D-printed PSI offers significant accuracy improvement in joint preserving surgery with a minimal increase in time and design costs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Ferrimagnetic devitrified glass doped with copper by ion exchange: Microstructure, bioactivity and antibacterial properties.
- Author
-
Miola, Marta, Bruno, Matteo, and Vernè, Enrica
- Subjects
- *
COPPER ions , *ION exchange (Chemistry) , *GLASS-ceramics , *MAGNETITE , *FERRIMAGNETIC materials , *COPPER , *CALCIUM ions , *BIOACTIVE glasses - Abstract
In this work, the ion-exchange technique in molten salts was investigated to introduce copper ions in a bioactive and ferrimagnetic devitrified glass. This approach aimed to develop a magnetic and bioactive material for oncologic bone implants, able to join the ability to promote bone bonding to hyperthermic therapy while simultaneously lowering the risk of developing post-surgery infections. The ion-exchange approach was developed in order to overcome experimental critical issues related to the influence of copper introduction as a starting reagent, during the material synthesis, on magnetite nucleation. The magnetic devitrified glass was prepared by melt and quenching route, followed by ion exchange in a mixture of molten sodium and copper nitrates, in three different Na/Cu molar ratios (20, 200, 2000). The obtained samples were analysed in terms of morphology, composition, ability to release heat, bioactivity and antibacterial properties. The results revealed that copper ion-exchange involved both sodium and calcium ions and the precipitation of few amounts of copper oxide aggregates occurred. The crystalline nature of the starting material and its ability to reach the temperature needed for hyperthermia, under exposition to an alternating magnetic field, were not affected. A bacteriostatic effect was obtained by samples with the highest copper amount and the copper doping did not affect the bioactivity of the glass ceramic. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Short- and Long-Term Outcomes after Radiofrequency Ablation of Osteoid Osteomas.
- Author
-
Vogl, Thomas J., Bialek, Michael, Eichler, Katrin, Hammerstingl, Renate, Bielfeldt, John, Zangos, Stephan, Scholtz, Jan-Erik, and Adwan, Hamzah
- Subjects
- *
CATHETER ablation , *PATIENT satisfaction , *TREATMENT effectiveness , *SLEEP disorders , *QUALITY of life , *SELF medication - Abstract
The aim of this study was to evaluate treatment of osteoid osteomas using bipolar radiofrequency ablation (RFA) and patients' quality of life before and after therapy. We retrospectively evaluated patients who underwent bipolar RFA of osteoid osteomas between 2001 and 2016. We assessed patients' symptoms before and after treatment (four weeks after treatment and long-term) using a questionnaire including severity and quality of pain on a 10-point scale (1 = no pain, 10 = severe pain), motion restrictions, pain-related sleep disorders, and necessary pain medication. In addition, we evaluated technical success, complications, hospitalization length, and patients' satisfaction with treatment. This study included 62 patients (43 [69.4%] males, 26.2 ± 13.2 years). Average nidus size was 5.7 ± 2.6 mm. The rate of technical success was 100%. All RFAs were performed without any complications. One patient showed a recurrence, resulting in a recurrence rate of 1.6%, which was successfully treated by another session of RFA. Average hospitalization length was 1.5 ± 0.5 days. A total of 36 patients (58.1%) participated in the questionnaire, reporting an average pain severity of 8.2 ± 1.6 before RFA compared to 3.4 ± 3.0 four weeks after and an average of 2.1 ± 2.3, 6.6 years after therapy, (both p < 0.001). After therapy, 31 (86.1%) patients had no pain. The majority of patients (n = 34, 94.4%) had reduced or absent motion restriction after therapy (p < 0.001). Patient satisfaction rate was 91.7%. In conclusion, bipolar RFA is a safe and effective treatment modality for osteoid osteomas and improves quality of life by reducing pain severity and motion restrictions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Diagnostic Performance of Artificial Intelligence in Detection of Primary Malignant Bone Tumors: a Meta-Analysis.
- Author
-
Salehi, Mohammad Amin, Mohammadi, Soheil, Harandi, Hamid, Zakavi, Seyed Sina, Jahanshahi, Ali, Shahrabi Farahani, Mohammad, and Wu, Jim S.
- Subjects
PREDICTION models ,ARTIFICIAL intelligence ,CINAHL database ,BONE tumors ,META-analysis ,DESCRIPTIVE statistics ,SYSTEMATIC reviews ,MEDLINE ,ONLINE information services ,CONFIDENCE intervals ,MACHINE learning ,ALGORITHMS ,SENSITIVITY & specificity (Statistics) - Abstract
We aim to conduct a meta-analysis on studies that evaluated the diagnostic performance of artificial intelligence (AI) algorithms in the detection of primary bone tumors, distinguishing them from other bone lesions, and comparing them with clinician assessment. A systematic search was conducted using a combination of keywords related to bone tumors and AI. After extracting contingency tables from all included studies, we performed a meta-analysis using random-effects model to determine the pooled sensitivity and specificity, accompanied by their respective 95% confidence intervals (CI). Quality assessment was evaluated using a modified version of Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) and Prediction Model Study Risk of Bias Assessment Tool (PROBAST). The pooled sensitivities for AI algorithms and clinicians on internal validation test sets for detecting bone neoplasms were 84% (95% CI: 79.88) and 76% (95% CI: 64.85), and pooled specificities were 86% (95% CI: 81.90) and 64% (95% CI: 55.72), respectively. At external validation, the pooled sensitivity and specificity for AI algorithms were 84% (95% CI: 75.90) and 91% (95% CI: 83.96), respectively. The same numbers for clinicians were 85% (95% CI: 73.92) and 94% (95% CI: 89.97), respectively. The sensitivity and specificity for clinicians with AI assistance were 95% (95% CI: 86.98) and 57% (95% CI: 48.66). Caution is needed when interpreting findings due to potential limitations. Further research is needed to bridge this gap in scientific understanding and promote effective implementation for medical practice advancement. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Giant solitary acetabular osteochondroma with a 30-year-old neglected fracture neck femur treated with total hip arthroplasty: A case report
- Author
-
Vikram I. Shah, Javahir A. Pachore, Dhavalkumar L. Mungra, Gautam M. Shetty, and Jayesh Patil
- Subjects
Osteochondroma ,Hip ,Total hip arthroplasty ,Neglected fracture ,Bone tumor ,Orthopedic surgery ,RD701-811 - Abstract
Background: Outcome of total hip arthroplasty (THA) in a patient with a giant solitary acetabular osteochondroma and a 30-year-old neglected fracture neck femur with a high-riding dislocated hip has never been described. Case report: A 60-year-old female with a 30-year-old untreated fracture neck femur with resorbed femur head and a giant intra-articular acetabular osteochondroma was managed by tumor excision and THA surgery. At a follow up of 1 year, function improved significantly, with a limb length discrepancy of 1cm, and no evidence of tumor recurrence. Conclusion: Despite the complexity of the surgical technique, tumor excision with concomitant THA surgery achieved excellent results in the short-term.
- Published
- 2024
- Full Text
- View/download PDF
45. The survival and complication profiles of the Compress® Endoprosthesis: A systematic review and meta-analysis
- Author
-
Haolong Li, Xinxin Zhang, Xinyu Li, Jingnan Shen, Junqiang Yin, Changye Zou, Xianbiao Xie, Gang Huang, and Tiao Lin
- Subjects
Compress® endoprosthesis ,Survival curve ,Complication ,Bone tumor ,Limb salvage ,Meta-analysis ,Diseases of the musculoskeletal system ,RC925-935 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background/purpose: This study aimed to summarize the survival and complication profiles of the compress® endoprosthesis (CPS) through a systematic review and meta-analysis. Methods: Online databases (PubMed, EMBASE and Web of Science) were searched from inception to November 2023. Trials were included that involved the use of CPS for endoprosthetic replacement in patients with massive segmental bone defects. Patients’ clinical characteristics and demographic data were extracted using a standardized form. The methodological quality of included 13 non-comparative studies was assessed on basis of the Methodological Index for Non-Randomized Studies (MINORS). All the available Kaplan-Meier curves in the included studies were digitized and combined using Engauge-Digitizer software and the R Project for Statistical Computing. Results: The meta-analysis of thirteen included studies indicated: the all-cause failure rates of CPS were 26.3 % after surgery, in which the occurrence rates of aseptic loosening were 5.8 %. And the incidences of other complications were as follows: soft tissue failure (1.8 %), structure failure (8.2 %), infection (9.5 %), tumor progression (1.1 %). The 1-, 4-, and 8-year overall survival rates for all-cause failure with 95 % CI were 89 % (86 %-92 %), 75 % (71 %-79 %) and 65 % (60 %-70 %), respectively. The estimated mean survival time of all-cause failure was 145 months (95 % CI, 127–148 months), and the estimated median survival time of all-cause failure was 187 months (95 % CI, 135–198 months). The 1-, 4-, and 8-year overall survival rates of aseptic loosening with 95 % CI were 96 % (94 %-98 %), 91 % (87 %-95 %) and 88 % (83 %-93 %), respectively. The estimated mean survival time of aseptic loosening was 148 months (95 % CI, 137–153 months). Conclusion: CPS’s innovative spring system promotes bone ingrowth by providing immediate and high-compression fixation, thereby reducing the risk of aseptic loosening caused by stress shielding and particle-induced osteolysis. CPS requires less residual bone mass for reconstructing massive segmental bone defects and facilitates easier revision due to its non-cemented fixation. In addition, the survival rate, estimated mean survival time, and complication rates of CPS are not inferior to those of common endoprosthesis.
- Published
- 2024
- Full Text
- View/download PDF
46. A case of bone tumor-induced compartment syndrome.
- Author
-
Chaudhry, Nadeem, Qureshi, Abid, Sultana, Mosammath, Pawanarkar, Meehika, and Rizwan, Muhammad
- Subjects
- *
COMPARTMENT syndrome , *SURGICAL emergencies , *FORELIMB , *OPERATING rooms , *FASCIOTOMY - Abstract
Compartment syndrome is a rare critical condition that can arise in individuals with cancer, presenting with significant challenges in diagnosis and management. Compartment syndrome occurs when the pressure within a closed fascial space rises to a point that restricts circulation. A 56 year-old male patient presented with 2 days of pain and swelling in the right upper extremity pain. Physical examination was remarkable for right upper extremity erythema swelling and tense compartments, concerning for compartment syndrome. Humerus X-ray showed moth eaten appearance of mid humerus with periosteal reaction and fracture. Patient was taken to the operating room for anterior and posterior compartment fasciotomies. Compartment syndrome is a surgical emergency, for which fasciotomy is generally performed. Pathology has rarely been linked to malignancy, with seldom reports examining causation. More research regarding pathophysiology of cancer in relation to compartment syndrome needs to be conducted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. A Dose Finding Study to Treat Bone Tumor(s)
- Published
- 2023
48. Intraosseous hibernoma mimicking sclerotic bone metastasis—a case report
- Author
-
Shaikh, Ali, Basha, Adil, Ray, George, Bishop, Justin A., and Chhabra, Avneesh
- Published
- 2024
- Full Text
- View/download PDF
49. Gait analysis of patients undergoing knee endoprosthesis: functional differences between tibia and femur resections
- Author
-
Almeida, Leonardo L., Prada, Lidia Maria, Caldas, Carla T., Gava, Nelson F., and Engel, Edgard E.
- Published
- 2024
- Full Text
- View/download PDF
50. Tibial Adamantinoma: A Case Report from a Resource-Limited-Setting
- Author
-
Yaynishet YA, Fayisa ST, Dencha BA, and Hailu SS
- Subjects
adamantinoma ,bone tumor ,ethiopia ,Medicine (General) ,R5-920 - Abstract
Yodit Abraham Yaynishet,1 Shimalis Tadasa Fayisa,2 Bereket Amare Dencha,3 Samuel Sisay Hailu1 1Department of Radiology, Addis Ababa University, Addis Ababa, Ethiopia; 2Department of Radiology, Mizan Tepi University, Mizan, Ethiopia; 3Department of Pathology, Bahir Dar University, Bahir Dar, EthiopiaCorrespondence: Yodit Abraham Yaynishet, Department of Radiology, Addis Ababa University, P.O. Box: 9080, Addis Ababa, Ethiopia, Email yodit.abraham@aau.edu.etIntroduction: Adamantinoma is an infrequent, low-grade malignant bone tumor, predominantly affecting the tibia and often presents diagnostic challenges due to its nonspecific radiographic characteristics.Case Presentation: A 55-year-old military personnel, with no history of trauma, who presented with a one-year history of right leg swelling and pain. Radiological examination showed right anterior tibial, mid diaphyseal lytic expansile lesion with internal trabeculations and excisional biopsy led to the diagnosis of adamantinoma. Below knee amputation was done as a definitive management.Conclusion: Despite diagnostic challenges adamantinoma presents, the patient was referred to oncology and underwent amputation, underscoring the importance of considering adamantinoma in differential diagnosis for persistent bone lesions.Keywords: adamantinoma, bone tumor, Ethiopia
- Published
- 2024
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.